Vertex pharmaceuticals incorporated and ribometrix, inc establish strategic collaboration to discover and develop rna-targeted small molecule therapeutics

Vertex pharmaceuticals incorporated and ribometrix, inc. announced that the companies have entered into a strategic collaboration to discover and develop novel rna-targeted small molecule therapeutic candidates for serious diseases. the collaboration will combine ribometrix’s proprietary discovery platform for identifying and optimizing small molecule therapeutics that modulate rna function by targeting three-dimensional (3d) rna structures with vertex’s scientific, clinical and regulatory capabilities for up to three therapeutic programs, including one ongoing discovery program from ribometrix.
VRTX Ratings Summary
VRTX Quant Ranking